External Affairs Minister S. Jaishankar has had a hectic day and a half in Washington DC, where he met government officials, including National Security Advisor Jake Sullivan and the U.S. Trade Representative (USTR) ambassador Katherine Tai, lawmakers, and the private sector.
The Ministry of Home Affairs (MHA) on Thursday repeated the guidelines (under the Disaster Management Act, 2005) issued on April 29 to implement containment measures in districts where either the test positivity is more than 10 % in the past one week or where the bed occupancy is more than 60%.
The Centre on Thursday told the Madras High Court that the demand for liposomal amphotericin-B (LAmB), a drug used for treating mucormycosis, has exceeded the supply available through domestic production as well as imports and therefore, the government had to regulate the supply to the States to avoid hoarding and inequitable distribution.
Updated:
May 28, 2021 23:46 IST
It said that as on date, India was using three vaccines against COVID-19 in its immunisation drive
Share Article
AAA
A health worker shows Covishield and Covaxin vaccines, in Bengaluru. File
| Photo Credit:
K. Murali Kumar
It said that as on date, India was using three vaccines against COVID-19 in its immunisation drive The Central government is holding regular talks with national and international vaccine manufacturers like Pfizer, Moderna etc. to make COVID-19 vaccines available in the country, said the Health Ministry on Friday in a statement.
It said that as on date, India was using three vaccines against COVID-19 in its immunisation drive. This included two ‘made in India’ vaccines Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin, who have supplied about 7.92 crore vaccine doses in the month of May 2021.